A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

May 19, 2017

Study Completion Date

May 26, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-831

TAK-831 film-coated tablet.

Trial Locations (1)

66219

PRA Health Sciences, Lenexa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Neurocrine Biosciences

INDUSTRY